In this Issue:
5-year vs 10-year tamoxifen
Impact of premenopausal status at diagnosis
Risk of ischaemic heart disease after radiotherapy
Pain outcomes of denosumab vs zoledronic acid
Adjuvant chemotherapy and survival after development of metastases
Long-term follow-up of molecular phenotypes
Trastuzumab emtansine versus trastuzumab plus docetaxel
Meta-analysis of SLND vs ALND
Adjuvant trastuzumab and CNS relapses
Systematic review of vinorelbine
Please login below to download this issue (PDF)